Why the study?
Does the measurement of natriuretic peptides assist in the diagnosis and prognosis of heart failure and post-myocardial infarction?
Does the measurement of natriuretic peptides assist in the diagnosis and prognosis of heart failure and post-myocardial infarction?
BNP is a valuable prognostic marker in heart failure and aids in the diagnostic evaluation of dyspnea, but must be used in conjunction with clinical assessment rather than as a stand-alone test.
No takes yet. Share an insight, caveat, or question.
Supports BNP integration with clinical assessment in HF evaluation; extends prior syntheses but leaves open need for contemporary validation.
Lijnen et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: